MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Repare Therapeutics Inc. (RPTX)

Repare Therapeutics Inc. (RPTX)

|||

Balance Sheets Overview

Current Ratio
1070.79%
Quick Ratio
1070.79%
Cash Ratio
626.72%
Debt to Asset Ratio
9.17%
Unit: Thousand (K) dollars
Assets Breakdown
    • Total current assets
    • Investment in equity securities
    • Other assets
    • Others
Liabilities Breakdown
    • Common shares, no par value per ...
    • Accumulated deficit
    • Additional paid-in capital
    • Others
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
72,825
67,656
Marketable securities
39,779
41,816
Income tax receivable
1,802
9,922
Other current receivables
6,487
4,697
Prepaid expenses
3,533
2,481
Total current assets
124,426
126,572
Property and equipment, net
0
72
Operating lease right-of-use assets
0
629
Income tax receivable
0
1,029
Investment in equity securities
1,721
1,591
Other assets
600
600
Total assets
126,747
130,493
Accounts payable
1,334
4,012
Accrued expenses and other current liabilities
9,944
12,167
Deferred collaboration cost recovery
-
3,257
Operating lease liability, current portion
342
649
Total current liabilities
11,620
20,085
Operating lease liability, net of current portion
0
0
Total liabilities
11,620
20,085
Preferred shares, no par value per share unlimited shares authorized as of september 30, 2025 and december 31, 2024 0 shares issued and outstanding as of september 30, 2025, and december 31, 2024
0
0
Common shares, no par value per share unlimited shares authorized as of september 30, 2025 and december 31, 2024 42,985,755 and 42,510,708 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
490,487
490,425
Warrants
60
43
Additional paid-in capital
85,893
84,533
Accumulated other comprehensive income
14
-8
Accumulated deficit
-461,327
-464,585
Total shareholders equity
115,127
110,408
Total liabilities and shareholders equity
126,747
130,493
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$72,825K Marketable securities$39,779K Other currentreceivables$6,487K Prepaid expenses$3,533K Income tax receivable$1,802K Total current assets$124,426K Investment in equitysecurities$1,721K Other assets$600K Total assets$126,747K Total liabilities andshareholders equity$126,747K Total shareholdersequity$115,127K Total liabilities$11,620K Accumulated deficit-$461,327K Common shares, no parvalue per share...$490,487K Total currentliabilities$11,620K Additional paid-in capital$85,893K Warrants$60K Accumulated othercomprehensive income$14K Accrued expenses andother current...$9,944K Accounts payable$1,334K Operating leaseliability, current portion$342K